Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Xbrane Biopharma Major Shareholding Notification 2020

Jun 4, 2020

3128_iss_2020-06-04_ea3049ff-a6f4-4611-9e72-65449ac6b1c0.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Xbrane Biopharma AB

Holder

Serendipity Group AB

Instrument

Instrument Shares
Before the transaction
Shares 0
Voting rights 0
Transaction
Date 01/06/2020
Limit for number of shares 10 %
Limit for number of votes 10 %
After the transaction

Quantity

Shares 2,819,967
Directly held voting rights 2,819,967
Indirectly held voting rights 0

Percentage

Directly held shares 14.63474 %
Directly held voting rights 14.63474 %
Indirectly held voting rights 0 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 14.63474 % 2,819,967
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 14.63474 % 2,819,967
Group total holdings
Voting rights
2,819,967

Percentage of voting rights 14.63474

Notes (other relevant informations according to law)

Orsak till flaggning: Flaggningen avser återleverans av utlånade aktier (2 255 974 stycken) i samband med nyemission i Xbrane Biopharma AB samt teckning och tilldelning av aktier i nämnda nyemission (563 993 stycken). Flaggningen är baserad på 19 268 998 utestående aktier i Xbrane Biopharma AB.

Published

04/06/2020 15:56

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25